Cyclerion Therapeutics, Inc.
CYCN
$3.00
-$0.01-0.33%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.18M | -799.00K | -976.00K | -324.00K | -1.43M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 58.00K | 95.00K | 118.00K | 114.00K | 114.00K |
| Change in Net Operating Assets | 1.94M | -875.00K | 594.00K | -293.00K | 347.00K |
| Cash from Operations | -1.18M | -1.58M | -264.00K | -503.00K | -968.00K |
| Capital Expenditure | -66.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -66.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 825.00K | 251.00K | 1.83M | 0.00 | 1.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -130.00K | -- |
| Cash from Financing | 825.00K | 251.00K | 1.83M | -130.00K | 1.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -417.00K | -1.33M | 1.56M | -633.00K | 407.00K |